Use of botulinum toxin type A in management of adult spasticity--a European consensus statement.
نویسندگان
چکیده
Anthony B. Ward, Miguel Aguilar, Zegers De Beyl, Susanne Gedin, Petr Kanovsky, Franco Molteni, Jörg Wissel and Anton Yakovleff From the Department of Rehabilitation Medicine, North Staffordshire Hospital, Stoke-on Trent, UK, Department of Neurology, Hospital Mutua Terrassa, Barcelona, Spain, Department of Neurology, Hôpital Erasme, Université Libre de Bruxelles, Belgium, Department of Neurology, Helsingborg Hospital, Sweden, Department of Neurology, Masaryk University, Brno, Czech Republic, Movement Disorders Rehabilitation Unit, Valduce Rehabilitation Centre, Costa Masnaga, Lecco, Italy, Department of Neurology, Clinic for Neurorehabilitation, Beelitz-Heilstatten, Germany, Clinical Neurology, Université de Paris V-René Descartes, France
منابع مشابه
European consensus table on the use of botulinum toxin type A in adult spasticity.
A group of clinicians from across Europe experienced in the use of botulinum toxin type A for the treatment of spasticity following acquired brain injury gathered to develop a consensus statement on best practice in managing adults with spasticity. This consensus table summarizes the current published data, which was collated following extensive literature searches, their assessment for level o...
متن کاملEuropean consensus statement on the use of botulinum toxin type A in the management of adult spasticity.
Spasticity commonly follows damage to the central nervous system (brain and spinal cord) and presents in conditions, such as stroke, brain and spinal injury of traumatic and non-traumatic causes, multiple sclerosis, cerebral palsy and in a variety of ways depending on the size, location and age of the lesion. It is an involuntary muscle overactivity, which may have several harmful effects such ...
متن کاملPan-Arab consensus statement on the use of botulinum toxin type A in spasticity management.
tendon jerks, resulting from hyperexcitability of the stretch reflex.”1 Spasticity can produce impairment of active functions performed by the patient such as reaching, transferring, and walking, as well as disabling symptoms of pain, spasm, and disfigurement, disturbance in passive functions when the patient is being assisted by a caregiver, such as excessive tone in a limb during washing, bat...
متن کاملBotulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement.
Botulinum neurotoxin type-A (BoNT-A) has been used in association with other interventions in the management of spasticity in children with cerebral palsy (CP) for almost two decades. This consensus statement is based on an extensive review of the literature by an invited international committee. The use of BoNT-A in the lower limbs of children with spasticity caused by CP is reported using the...
متن کاملThe Effect of Foot Serial Casting Along with Botulinum Toxin Type-A Injection on Spasticity in Children with Cerebral Palsy
Background & Aims: The goal of this study was to determine the effect of foot serial casting along with botulinum toxin type-A injection on spasticity in children with cerebral palsy. Methods: This study was a randomized clinical trial performed as a pre-post, double blind study. It was performed on 25 children with hemiplegia and diplegia (2-8 years) in Tehran city, who were referred to valias...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of rehabilitation medicine
دوره 35 2 شماره
صفحات -
تاریخ انتشار 2003